Tech Company Inital Public Offerings
Clovis Oncology IPO
Clovis Oncology was acquired by . The company's stock were listed on 11/15/2011.
Transaction Overview
Company Name
Announced On
11/15/2011
Transaction Type
IPO
Amount
$130,000,000
Proceeds Purpose
Proceeds purposes are on file with company statements at the SEC.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
5500 Flatiron Pkwy.
Boulder, CO 80301
USA
Boulder, CO 80301
USA
Phone
Website
Email Address
Overview
Clovis Oncology is a biopharmaceutical company focused on acquiring, developing and commercializing anti-cancer agents.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Patrick Mahaffy
Chief Medical Officer
Lindsey Rolfe
VP - Finance
Daniel Muehl
VP - General Counsel
Paul Gross
VP - Human Resources
Ann Bozeman
VP - Regulatory Affairs
Gillian Ivers-Read
Browse more venture capital transactions:
Prev: 11/15/2011: YuMe venture capital transaction
Next: 11/15/2011: NexGen Storage venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to document every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs